InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,188.31
(
0.15%
)
US TECH 100
17,618.40
(
0.05%
)
Dow Jones
38,896.91
(
0.11%
)
Brent Oil
83.10
(
-0.46%
)
Bitcoin
63,020.22
(
-0.23%
)
Post# of 146206
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

BonelessCat

Send PM Follow Ignore
Followers 261
Posts 19732
Boards Moderated 0
Alias Born 10/03/2004

BonelessCat

Re: Ligander post# 47209

Wednesday, 03/09/2011 2:13:45 PM

Wednesday, March 09, 2011 2:13:45 PM

Post# of 146206
You are posting from the same source that has already been debunked.

As I have stated repeatedly and evidenced, The base drug in Alimta IS NOT ALIMTA!!! Alimta is the marketing name for the base drug plus all the buffers and other materials that make it work in humans. Dr. Menon was the lead researcher and principle in the discovery process that allowed the base drug to go from a university project to a marketable drug.

Menon has a Ph.D. in Pharmacology from Harvard. he is also a certified toxicologist. In addition, he is a Doctor of Veterinary Medicine, which makes his contributions invaluable to pre-clinical discovery for effective and safe drug design.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NNVC News
More NNVC News
InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!